全球糖化血红素（HbA1c）检测市场规模、份额、趋势及成长分析报告（2026-2034年）

HbA1c 检测市场预计将从 2025 年的 24.9 亿美元成长到 2034 年的 70.2 亿美元，2026 年至 2034 年的复合年增长率为 12.2%。

由于糖尿病盛行率不断上升以及人们对预防性护理的日益重视，HbA1c检测市场预计将迎来显着成长。随着医疗机构致力于糖尿病的早期诊断和管理，HbA1c检测已成为监测长期血糖控制的重要工具。此检测不仅有助于诊断糖尿病，而且在评估治疗方案的有效性方面也发挥关键作用，使其成为糖尿病护理的重要组成部分。

诊断检测技术的进步正在改变糖化血红蛋白（HbA1c）检测的模式。就地检验设备的创新提高了检测的可及性和便利性，使患者能够更有效地管理血糖值。这些设备能够快速提供检测结果，从而实现及时介入和个人化治疗方案。此外，行动应用程式和远端医疗等数位健康解决方案的整合提高了患者的参与度和治疗通讯协定的依从性，最终改善了整体健康状况。

人们对糖尿病管理重要性的认识不断提高，也推动了市场扩张。公共卫生措施旨在教育大众了解糖尿病控制不佳的风险，促使更多人寻求定期检测。随着医疗保健系统日益重视以价值为导向的医疗服务，对可靠、准确的糖化血红蛋白（HbA1c）检测解决方案的需求预计将进一步增长。在这种不断变化的环境中，相关人员已做好充分准备，掌握HbA1c检测市场的成长潜力，推动创新，并在此过程中改善患者照护。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球糖化血红素检测市场（依产品类型划分）

• 市场分析、洞察与预测
• 装置
• 试剂
• 成套工具

5. 全球糖化血红素 (HbA1c) 检测市场（依技术划分）

• 市场分析、洞察与预测
• 离子交换高效液相层析法
• 酵素法
• 亲和性和结合层析法
• 浊度免疫抑制检测法
• 其他的

6. 全球糖化血红素检测市场（依最终用户划分）

• 市场分析、洞察与预测
• 医院和诊所
• 诊断检查室
• 居家照护
• 研究所
• 其他的

7. 全球糖化血红素检测市场（按地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott
  • Bio-Rad LaboratoriesInc
  • ARKRAYInc
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH
  • TransAsia Bio-Medicals
  • Trinity Biotech Ireland
  • EKF Diagnostics
  • Randox Laboratories Ltd
  • HemoCue India
  • Eurolyser Diagnostica GmbH
  • Sekisui Diagnostics

The HbA1c Testing Market size is expected to reach USD 7.02 Billion in 2034 from USD 2.49 Billion (2025) growing at a CAGR of 12.2% during 2026-2034.

The HbA1c testing market is poised for significant growth, driven by the rising prevalence of diabetes and the increasing emphasis on preventive healthcare. As healthcare providers focus on early diagnosis and management of diabetes, HbA1c testing has emerged as a critical tool for monitoring long-term glucose control. This test not only aids in the diagnosis of diabetes but also plays a vital role in assessing the effectiveness of treatment regimens, making it indispensable in diabetes care.

Technological advancements in diagnostic testing are reshaping the HbA1c testing landscape. Innovations in point-of-care testing devices are enhancing accessibility and convenience, allowing patients to monitor their glucose levels more effectively. These devices provide rapid results, enabling timely interventions and personalized treatment plans. Furthermore, the integration of digital health solutions, such as mobile applications and telemedicine, is facilitating better patient engagement and adherence to treatment protocols, thereby improving overall health outcomes.

The growing awareness of the importance of diabetes management is also driving market expansion. Public health initiatives aimed at educating individuals about the risks associated with uncontrolled diabetes are prompting more people to seek regular testing. As healthcare systems increasingly prioritize value-based care, the demand for reliable and accurate HbA1c testing solutions is expected to rise. In this evolving environment, stakeholders are well-positioned to capitalize on the growth potential of the HbA1c testing market, driving innovation and improving patient care in the process.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Instruments
• Reagents
• Kits

By Technology

• Ion-exchange HPLC
• Enzymatic assay
• Affinity binding chromatography
• Turbidimetric inhibition immunoassay
• Others

By End User

• Hospitals and clinics
• Diagnostic laboratories
• Homecare
• Research institution
• Others

COMPANIES PROFILED

• Abbott, BioRad Laboratories, Inc, ARKRAY, Inc, Danaher, F HoffmannLa Roche Ltd, Siemens Healthcare GmbH, TransAsia BioMedicals, Trinity Biotech Ireland, EKF Diagnostics, Randox Laboratories Ltd, HemoCue India, Eurolyser Diagnostica GmbH, Sekisui Diagnostics

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HBA1C TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN and Units)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 4.4. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 5. GLOBAL HBA1C TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN and Units)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Ion-exchange HPLC Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.3. Enzymatic assay Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.4. Affinity binding chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.5. Turbidimetric inhibition immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 6. GLOBAL HBA1C TESTING MARKET: BY END USER 2022-2034 (USD MN and Units)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.3. Diagnostic laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.4. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.5. Research institution Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 7. GLOBAL HBA1C TESTING MARKET: BY REGION 2022-2034(USD MN and Units)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.2.1 By Product Type
  • 7.2.2 By Technology
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.3.1 By Product Type
  • 7.3.2 By Technology
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.4.1 By Product Type
  • 7.4.2 By Technology
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.5.1 By Product Type
  • 7.5.2 By Technology
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.6.1 By Product Type
  • 7.6.2 By Technology
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HBA1C TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott
  • 9.2.2 Bio-Rad LaboratoriesInc
  • 9.2.3 ARKRAYInc
  • 9.2.4 Danaher
  • 9.2.5 F. Hoffmann-La Roche Ltd
  • 9.2.6 Siemens Healthcare GmbH
  • 9.2.7 TransAsia Bio-Medicals
  • 9.2.8 Trinity Biotech Ireland
  • 9.2.9 EKF Diagnostics
  • 9.2.10 Randox Laboratories Ltd
  • 9.2.11 HemoCue India
  • 9.2.12 Eurolyser Diagnostica GmbH
  • 9.2.13 Sekisui Diagnostics